Epratuzumab Human Monoclonal Antibody
Epratuzumabis a research-grade recombinant antibody targeting CD22. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
Sialic acid-binding Ig-like lectin 2, Siglec-2, CD22, T-cell surface antigen Leu-14, BL-CAM, SIGLEC2, B-lymphocyte cell adhesion molecule, B-cell receptor CD22
UniProt
P20273
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human Humanized
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG1-nd
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Rabbit Monoclonal CD48/SLAMF2 Antibody (CD48/8360R) [Janelia Fluor 585]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
NBP3-21026JF585 0.1 mL
Rabbit Monoclonal CD48/SLAMF2 Antibody (CD48/8360R) [Janelia Fluor 585]
Sign In for Pricing
View Details 
LH02467V 100 µg
Alpha 2 Glycine Receptor (GLRA2) (NM_001118886) Human Over-expression Lysate
Sign In for Pricing
View Details 